Immune Profiling and Sequencing of Canine B Cell Lymphoma

Patient Disease:

Canine Lymphoma

Study Name:

Immune Profiling and Sequencing of Canine B Cell Lymphoma

Purpose of the study:

  • To perform immune profiling and sequencing of Canine B Cell Lymphoma

  • To determine whether these mutations are recognized by the immune system

  • Ultimately to use this information to generate more effective immunotherapies for this and other cancers of dogs

Primary Eligibility Criteria:

  • Dogs with multicentric B cell lymphoma 

  • Must be healthy enough for sedation and biopsy of the lymph node

Study Protocol:

  • Pre-enrollment:  confirm diagnosis, lymphoma phenotyping, confirm that dog has not been treated previously

  • Week 1: blood collection and biopsy

Owner Responsibilities:

  • Consent to biopsy and blood sampling

Financial Incentives:

  • The study will cover costs of the study procedures.

  • There is a $500.00 credit applied to the VTH account of the patient

    If you have further questions about any of our clinical trials, please submit an online consulting form. Your consult will then be directed to an appropriate oncology clinician. Requests are typically returned within 5 business days.